Steven Kelly is the founder of Carisma Therapeutics. Carisma Therapeutics has raised $120M in total funding. Latest round: Series B.
Steven Kelly is the CEO of Carisma Therapeutics, a clinical-stage biopharmaceutical company focused on developing a cell therapy platform for hard-to-treat cancers. He oversees Phase I oncology clinical trials and led the company after its first patient was dosed with CT-0508, a CAR-M therapy.
Full founder directory · Investor directory · Company funding database · Fundraising library